Bristol-Myers Squibb Beats Earnings Estimates and More - Presented by: The Aol. On Network

Bristol-Myers Squibb reported higher than expected quarterly earnings on Tuesday, helped by cost cuts and lower taxes. There were concerns over a possible delay in completing its marketing application for a high-profile cancer drug. BMY posted Q1 earnings of 56 cents per share, beating estimates of 43 cents a share, while revenue dipped to $3.81 billion, missing estimates of $3.89 billion. Bristol-Myers Squibb also announced the acquisition of iPierian for $175 million.



Related Videos

Most Popular Videos

Latest Videos


Most Active by Volume

Company Last Sale Change Net / %
BAC $ 16.06 0.05 ▲ 0.31%
PBR $ 19.66 0.54 ▲ 2.82%
AAPL $ 102.51 0.26 ▲ 0.25%
TWTR $ 49.66 0.23 ▲ 0.47%
INTC $ 34.805 0.16 ▲ 0.45%
SIRI $ 3.615 0.02 ▲ 0.42%
VALE $ 13.07 0.04 ▼ 0.31%
SPLK $ 53.53 8.24 ▲ 18.19%

As of 8/29/2014, 03:45 PM
More Most Active